Advances in Clinical Chemistry

Erscheinungsjahr 2022
ISBN: 978-0-323-98837-7
Verlag: William Andrew Publishing

Buch, Englisch, 298 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 450 g

Advances in Clinical Chemistry, Volume 106, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, with this new release focusing on Advances in ADAMTS biomarkers, Advances in fibrosis biomarkers in nonalcoholic fatty liver disease, Metabolomics of Peripheral Artery Disease, Molecular and cellular functions of long non-coding RNAS in prostate and breast cancer, Myostatin: Basic Biology to Clinical Application, and Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer.

Zielgruppe

Clinical Laboratory Professionals, Physicians and Research Scientists

Autoren/Hrsg.

Makowski, Gregory S.

Fachgebiete

• Naturwissenschaften Biowissenschaften Biochemie (nichtmedizinisch)

Inhaltsverzeichnis

1. Advances in ADAMTS biomarkers
Rahel Schnellmann
2. Advances in fibrosis biomarkers in nonalcoholic fatty liver disease
Stefano Ciardullo and Gianluca Perseghin
3. Metabolomics of peripheral artery disease
Ahmed Ismaeel, Ramon Lavado, and Panagiotis Koutakis
4. Molecular and cellular functions of long non-coding RNAs in prostate and breast cancer

Yuan-Shan Zhu and Jifeng Zhu
5. Myostatin: Basic biology to clinical application

Pasquale Esposito, Daniela Picciotto, Yuri Battaglia, Francesca Costigliolo, Francesca Viazzi, and Daniela Verzola
6. Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer

Muhammad T. Abdel Ghafar and Nema A. Soliman

Über Autor(innen)

Makowski, Gregory S.
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.